There is a high burden of illness associated with trigeminal neuralgia and current treatments do not fully meet patient needs, researchers told the American Pain Society's annual meeting. Carbamazepine is the only FDA-approved drug for trigeminal neuralgia, but other medications are used off-label to reduce the orofacial pain.
The Power Over Pain -- Coaching pain management intervention, created to give patients the perception they have control over pain, was found to improve pain measures among African-Americans with cancer, compared with a control group, according to a study reported at the American Pain Society's annual meeting. The POP-C program includes medication management, pain advocacy and aspects of living with pain.
The use of transcranial direct-current stimulation to treat knee osteoarthritis resulted in greater reductions in knee pain severity than a sham treatment, researchers told the American Pain Society's annual meeting. Researcher Brian Ahn of the University of Texas Health Center suggested the neuromodulatory effects of tDCS may be the mechanism for pain relief.
A population-based study in JAMA Neurology linked long-term opioid use among polyneuropathy patients to an increased risk of adverse events without improved function. Patients taking opioids for at least 90 days were more likely to rely on gait aids, have trouble climbing stairs, have depression, and experience opioid dependence and overdose, compared with patients in a control group.
Researchers told the American Pain Society's annual meeting that up to 85% of orthopedic surgery patients who completed opioid therapy after their procedures had unused medication, with an average of 30 leftover pills. Researchers said data from other surgical specialties showed similar results.
A study presented at the Society for Academic Emergency Medicine's annual meeting showed significant variation in opioid prescribing patterns for patients with minor injuries who were seen at hospital emergency departments. Overall, only 7% of patients got an opioid prescription in the ED, but the rates varied from 1.6% in Delaware to 16% in Mississippi.
The APS Scientific Program Committee (SPC) invites the submission of proposals for Focused Symposia for the 2018 Scientific Summit. Topics should align with the theme of understanding pain mechanisms and pain treatment mechanisms. Deadline to submit research is June 12, 2017. Learn more.